For the 11 million Americans living with angina, chronic chest pain caused by a lack of blood flow to the heart muscle can touch every aspect of daily ...

PARIS — After the first major prospective study to associate percutaneous intervention (PCI) with symptom relief in stable angina captured international attention, a new analysis of the ...

ATLANTA, GA—An implantable coronary sinus reducer (CSR) in patients with refractory angina significantly reduces symptoms over 6 months of follow-up compared with a placebo procedure, a new study ...

PHILADELPHIA, PA—More than 6 years since the placebo-controlled ORBITA trial set the interventional cardiology galaxy whirling, ORBITA-2, attempting to isolate the treatment effects of PCI alone, ...

ATLANTA -- For people with stable coronary artery disease and refractory angina, a coronary sinus reducer (CSR) implant showed a symptom alleviation benefit in the small placebo-controlled ...

Please provide your email address to receive an email when new articles are posted on . Gene therapy may be an effective treatment for “no-option” refractory angina. XC001 improved exercise capacity ...

Schizophrenia is associated with an increased risk of subsequent cardiovascular disease (CVD) events, with the association stronger in women, according to a study published online Feb. 27 in the ...

High cholesterol is often called a “silent condition” because it usually develops without obvious symptoms. However, once it begins affecting blood circulation and the arteries, certain physical signs ...

Blocked arteries in the heart are a serious health problem that affects millions of people around the world. Doctors call ...

Sometimes, a study on one topic can reveal important issues in another. Case in point: A recent Lancet study explored what a person’s life was like before they developed chronic pain — the diseases ...